Lv21
196 积分 2025-06-25 加入
Harnessing the biology of regulatory T cells to treat disease
14天前
已完结
Treg cells in autoimmunity: from identification to Treg-based therapies
30天前
已完结
An iPSC-derived CD19/BCMA CAR-NK therapy in a patient with systemic sclerosis
1个月前
已完结
OxLDL-Targeted Chimeric Antigen Receptor T Regulatory Cells Reduce Atherosclerotic Plaque Development
2个月前
已完结
Intraperitoneal infusion of NKG2D CAR-NK cells induces endogenous CD8+ T cell activation in patients with advanced colorectal cancer
2个月前
已完结
Large-scale generation of iNK and CAR-iNK cells from CD34+ haematopoietic stem and progenitor cells for adoptive immunotherapy
3个月前
已完结
NKG2D ligand expression on NK cells induces NKG2D-mediated cross-tolerization of cytokine signaling and reduces NK cell tumor immunity
3个月前
已关闭
NKG2D ligand expression on NK cells induces NKG2D-mediated cross-tolerization of cytokine signaling and reduces NK cell tumor immunity
3个月前
已关闭
Author Correction: NK cell receptor NKG2D sets activation threshold for the NCR1 receptor early in NK cell development
4个月前
已完结
Mechanisms behind therapeutic potentials of mesenchymal stem cell mitochondria transfer/delivery
4个月前
已完结
皖公网安备34019202002308
